Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: Cardiovascular PK/PD Modeling Study
NCT03098680Phase 1Terminated
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Apr 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of salbutamol, nicardipine, dobutamine, phenylephrine, verapamil and 1 more, sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Apr 2017; status: terminated.
02
Drugs
salbutamolnicardipinedobutaminephenylephrineverapamil
Beyond the preview
Go deeper on NCT03098680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03098680.